Prognostic Value of Serum Neurofilament Light Chain for Disease Activity in Patients with Relapsing Multiple Sclerosis: Results from Subgroup Analysis Based on Body Mass Index and Age from the Phase 3 ASCLEPIOS I/II Trials (P6-6.011)

Article de revue

Avec comité de lecture

Anne Cross, Tjalf Ziemssen, Douglas Arnold, Eric Thouvenot, Scott Zamvil, Alit Bhatt, Wenjia Wei, Ibolya Boer, Enrique Alvarez et Heinz Wiendl

Neurology, Vol.102(7_supplement_1)

09/04/2024

Résumé

Abstract only

1 Consultations de la notice

Titre: Prognostic Value of Serum Neurofilament Light Chain for Disease Activity in Patients with Relapsing Multiple Sclerosis: Results from Subgroup Analysis Based on Body Mass Index and Age from the Phase 3 ASCLEPIOS I/II Trials (P6-6.011)
Créateurs - sans rôle: Anne Cross
Tjalf Ziemssen
Douglas Arnold
Eric Thouvenot
Scott Zamvil
Alit Bhatt
Wenjia Wei
Ibolya Boer
Enrique Alvarez
Heinz Wiendl
Détails de publication: Neurology, Vol.102(7_supplement_1)
Identifiants: 99139448609311
Unité académique: Institut de Génomique Fonctionnelle - IGF
Langue: English
Type de ressource: Journal article